{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:00Z","timestamp":1786114920914,"version":"build-2736575974"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032366","name":"McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.rdc.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:20:59Z","timestamp":1778844059000},"page":"517-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases"],"prefix":"10.1016","volume":"52","author":[{"given":"Victor","family":"Mocanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Aminghafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rdc.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0961203320983445","article-title":"Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort","volume":"30","author":"Kernder","year":"2021","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.rdc.2026.03.003_bib2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1177\/0961203319868531","article-title":"Autoantibodies in SLE: prediction and the p value matrix","volume":"28","author":"Choi","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2026.03.003_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/263091","article-title":"Autoantibodies in systemic autoimmune disorders","volume":"2014","author":"Mahler","year":"2014","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.rdc.2026.03.003_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","article-title":"Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients","volume":"34","author":"Sherer","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2026.03.003_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.679613","article-title":"Autoantibody discovery, assay development and adoption: Death Valley, the sea of survival and beyond","volume":"12","author":"Fritzler","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib6","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1093\/rheumatology\/keaa729","article-title":"Comment on: the reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"60","author":"Mahler","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.gpb.2015.09.001","article-title":"Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus","volume":"13","author":"Zhu","year":"2015","journal-title":"Genom Proteom Bioinform"},{"key":"10.1016\/j.rdc.2026.03.003_bib8","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3389\/fimmu.2018.02682","article-title":"The utilization of autoantibodies in approaches to precision health","volume":"9","author":"Fritzler","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001140","article-title":"Systemic lupus in the era of machine learning medicine","volume":"11","author":"Zhan","year":"2024","journal-title":"Lupus Sci Med"},{"issue":"7","key":"10.1016\/j.rdc.2026.03.003_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/acr.23712","article-title":"Antinuclear antibody-negative systemic lupus erythematosus in an international inception cohort","volume":"71","author":"Choi","year":"2019","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.rdc.2026.03.003_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41584-025-01291-0","article-title":"Immune-cell profiling to guide stratification and treatment of patients with rheumatic diseases","volume":"21","author":"Rao","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2026.03.003_bib12","article-title":"Multi-omics-driven biomarker discovery in autoimmune diseases: a comprehensive review","volume":"16","author":"Y","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.rdc.2026.03.003_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.491160","article-title":"Mini-review: human microbiome and rheumatic diseases","volume":"10","author":"Vural","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.rdc.2026.03.003_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/BOR.0000000000001140","article-title":"Spatial transcriptomics: challenges and future directions in musculoskeletal diseases","volume":"38","author":"Delos Santos","year":"2026","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13075-017-1380-3","article-title":"Emerging technologies in autoantibody testing for rheumatic diseases","volume":"19","author":"Olsen","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2026.03.003_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neucom.2019.10.118","article-title":"A comprehensive survey on support vector machine classification: applications, challenges and trends","volume":"408","author":"Cervantes","year":"2020","journal-title":"Neurocomputing"},{"key":"10.1016\/j.rdc.2026.03.003_bib17","series-title":"XGBoost: A scalable tree boosting system","author":"Chen","year":"2016"},{"key":"10.1016\/j.rdc.2026.03.003_bib18","first-page":"429","article-title":"Enhanced recursive feature elimination","author":"Chen","year":"2007","journal-title":"IEEE"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J Roy Stat Soc B Stat Methodol"},{"issue":"2","key":"10.1016\/j.rdc.2026.03.003_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J Roy Stat Soc B Stat Methodol"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"issue":"10","key":"10.1016\/j.rdc.2026.03.003_bib25","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/bioinformatics\/btq134","article-title":"Permutation importance: a corrected feature importance measure","volume":"26","author":"Altmann","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.rdc.2026.03.003_bib26","first-page":"30","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017","journal-title":"Adv Neural Inf Process Syst"},{"issue":"8","key":"10.1016\/j.rdc.2026.03.003_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.679","article-title":"An autoantibody profile identified by human genome-wide protein arrays in rheumatoid arthritis","volume":"5","author":"Liu","year":"2024","journal-title":"MedComm"},{"issue":"9","key":"10.1016\/j.rdc.2026.03.003_bib28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/ard-2022-223105","article-title":"Autoantibodies identify primary Sjogren\u2019s syndrome in patients lacking serum IgG specific for Ro\/SS-A and La\/SS-B","volume":"82","author":"Longobardi","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2026.03.003_bib29","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA120.002119","article-title":"Identification of novel serological autoantibodies in takayasu arteritis patients using HuProt arrays","volume":"20","author":"Wen","year":"2021","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"10.1016\/j.rdc.2026.03.003_bib30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/annrheumdis-2020-219069","article-title":"Lupus or not? SLE risk probability index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus","volume":"80","author":"Adamichou","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005773","article-title":"Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relatives","volume":"11","author":"Aymon","year":"2025","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13075-025-03541-8","article-title":"Predicting rheumatoid arthritis progression from seronegative undifferentiated arthritis using machine learning: a deep learning model trained on the KURAMA cohort and externally validated with the ANSWER cohort","volume":"27","author":"Fujii","year":"2025","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.rdc.2026.03.003_bib33","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s10067-022-06109-y","article-title":"Prediction of diagnosis results of rheumatoid arthritis patients based on autoantibodies and cost-sensitive neural network","volume":"41","author":"Geng","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib34","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/acr.24795","article-title":"Unique serum immune phenotypes and stratification of Oklahoma native American rheumatic disease patients","volume":"75","author":"Slight-Webb","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"Pt 1","key":"10.1016\/j.rdc.2026.03.003_bib35","article-title":"Effectiveness of artificial intelligence in classification of connective tissue diseases in patients with anti-nuclear antibody (ANA) positivity","volume":"120","author":"Bosnal\u0131","year":"2026","journal-title":"Comput Biol Chem"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001125","article-title":"Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases","volume":"11","author":"Wang","year":"2024","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-92964-z","article-title":"Closed circuit artificial \u0131ntelligence model named morgaf for childhood onset systemic lupus erythematosus diagnosis","volume":"15","author":"Aliyev","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.rdc.2026.03.003_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ins.2022.11.139","article-title":"K-means clustering algorithms: a comprehensive review, variants analysis, and advances in the era of big data","volume":"622","author":"Ikotun","year":"2023","journal-title":"Inf Sci"},{"issue":"8","key":"10.1016\/j.rdc.2026.03.003_bib39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0961203316641770","article-title":"Multiparametric detection of autoantibodies in systemic lupus erythematosus","volume":"25","author":"Budde","year":"2016","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000356","article-title":"Autoantibody clustering of lupus-associated pulmonary hypertension","volume":"6","author":"Mizus","year":"2019","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-017-1345-y","article-title":"Cytokine and autoantibody clusters interaction in systemic lupus erythematosus","volume":"15","author":"Pacheco","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.rdc.2026.03.003_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100291","article-title":"Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study","volume":"20","author":"Guthridge","year":"2020","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/acr2.11343","article-title":"Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding HLA-DRB1 genotype associations and immunological and clinical manifestations","volume":"4","author":"Diaz-Gallo","year":"2022","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2026.03.003_bib44","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/rheumatology\/kez596","article-title":"Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients","volume":"60","author":"Sciascia","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.rdc.2026.03.003_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092406","article-title":"Three clinical clusters identified through hierarchical cluster analysis using initial laboratory findings in Korean patients with systemic lupus erythematosus","volume":"11","author":"Jung","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.rdc.2026.03.003_bib46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ard.2025.04.003","article-title":"New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity-could anti-LIN28A enhance precision in diagnostics?","volume":"84","author":"Parodis","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2026.03.003_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152819","article-title":"Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: a longitudinal cohort study","volume":"74","author":"Ibarguengoitia-Barrena","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79978-9","article-title":"Machine learning identifies cytokine signatures of disease severity and autoantibody profiles in systemic lupus erythematosus - a pilot study","volume":"14","author":"Pattanaik","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.rdc.2026.03.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2024.105760","article-title":"Cluster analysis of clinical manifestations assigns systemic lupus erythematosus-phenotype subgroups: a multicentre study on 440 patients","volume":"91","author":"Mariette","year":"2024","journal-title":"Jt Bone Spine"},{"issue":"5","key":"10.1016\/j.rdc.2026.03.003_bib50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jimmun\/vkae025","article-title":"Characterization of autoantibody profiles in clusters of systemic lupus erythematosus using a novel autoantigen discovery technology","volume":"214","author":"DiCillo","year":"2025","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2026.03.003_bib51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard-2022-223808","article-title":"Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes","volume":"82","author":"Choi","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2026.03.003_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.11.002","article-title":"Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity","volume":"98","author":"Molano-Gonzalez","year":"2019","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.rdc.2026.03.003_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003365","article-title":"Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters","volume":"9","author":"Cafaro","year":"2023","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.rdc.2026.03.003_bib54","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41397-019-0139-4","article-title":"Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients","volume":"20","author":"Ling","year":"2020","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"10.1016\/j.rdc.2026.03.003_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005291","article-title":"Autoantibody clusters in rheumatoid arthritis are not driven by antigen specificity or isotype","volume":"11","author":"van Mourik","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.rdc.2026.03.003_bib56","article-title":"Comprehensive autoantibody profiles in systemic sclerosis: clinical cluster analysis","volume":"13","author":"Hoppner","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2026.03.003_bib57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/RHU.0000000000000836","article-title":"Cluster analysis using Anti-Aminoacyl-tRNA synthetases and SS-A\/Ro52 antibodies in patients with polymyositis\/dermatomyositis","volume":"25","author":"Ohashi","year":"2019","journal-title":"J Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2026.03.003_bib58","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.rdc.2026.03.003_bib59","first-page":"132","article-title":"Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence","author":"Fiorentino","year":"2022","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib60","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12890-025-03722-w","article-title":"A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1756-185X.14443","article-title":"Two clusters of systemic lupus erythematosus patients with muscle involvement in a Chinese cohort","volume":"26","author":"Zhao","year":"2023","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib62","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/rheumatology\/keae361","article-title":"Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical-serological-pathological classification","volume":"64","author":"Yang","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.rdc.2026.03.003_bib63","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/annrheumdis-2018-214439","article-title":"Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes","volume":"78","author":"Spielmann","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2026.03.003_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005191","article-title":"Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies","volume":"11","author":"Robert","year":"2025","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12967-025-07469-0","article-title":"Systemic sclerosis: bridging clinical and molecular insights: results from the PRECISESADS study","volume":"24","author":"Dans-Caballero","year":"2025","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib66","first-page":"109","article-title":"To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis?","volume":"36","author":"Boonstra","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2026.03.003_bib67","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/rheumatology\/kex516","article-title":"Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis","volume":"57","author":"Aouizerate","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2026.03.003_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152537","article-title":"Clinical stratification of 1318 primary Sj\u00f6gren\u2019s syndrome patients","volume":"68","author":"Fang","year":"2024","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib69","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/kez335","article-title":"Unique Sj\u00f6gren\u2019s syndrome patient subsets defined by molecular features","volume":"59","author":"James","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.rdc.2026.03.003_bib70","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/art.40906","article-title":"Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis","volume":"71","author":"Sobanski","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib71","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae303","article-title":"From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis","volume":"25","author":"Koopman","year":"2024","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.rdc.2026.03.003_bib73","article-title":"Disease-associated immune cell endotypes in anti-MDA5-positive dermatomyositis using unbiased hierarchical clustering","volume":"15","author":"Guo","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib74","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13023-025-03921-y","article-title":"Anti-MDA5 antibody IgG1 subtype is associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis","volume":"20","author":"Wu","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rdc.2026.03.003_bib75","article-title":"Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients","volume":"14","author":"de Boysson","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2026.03.003_bib76","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jdv.20850","article-title":"Risk stratification in anti-MDA5+ dermatomyositis-related interstitial lung disease by using cluster analysis","volume":"40","author":"He","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib77","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.42308","article-title":"Identification of three different phenotypes in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease","volume":"75","author":"Xu","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib78","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/joim.13607","article-title":"Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis","volume":"293","author":"Jin","year":"2023","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2026.03.003_bib79","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.abd.2023.06.005","article-title":"A new proposal for phenotypic classification and outcome assessment of dermatomyositis based on clinical manifestations and serological testing","volume":"99","author":"Huang","year":"2024","journal-title":"An Bras Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2026.03.003_bib80","doi-asserted-by":"crossref","first-page":"304","DOI":"10.55563\/clinexprheumatol\/df2oc3","article-title":"Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses","volume":"40","author":"Yang","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 7","key":"10.1016\/j.rdc.2026.03.003_bib81","article-title":"A neural network approach to multi-biomarker panel discovery by high-throughput plasma proteomics profiling of breast cancer","volume":"7","author":"Zhang","year":"2013","journal-title":"BMC Proc"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib82","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13059-020-02015-1","article-title":"MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data","volume":"21","author":"Argelaguet","year":"2020","journal-title":"Genome Biol"},{"issue":"6","key":"10.1016\/j.rdc.2026.03.003_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063270","article-title":"Comparison of the capacity of several machine learning tools to assist immunofluorescence-based detection of anti-neutrophil cytoplasmic antibodies","volume":"25","author":"Bertin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rdc.2026.03.003_bib84","first-page":"71","article-title":"Rheumatology diagnostics utilizing artificial intelligence for ANA pattern identification and titre quantification","author":"Moghaddam","year":"2025","journal-title":"J Rheumatol"},{"issue":"19","key":"10.1016\/j.rdc.2026.03.003_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14196924","article-title":"Pilot study of AI-Assisted ANA immunofluorescence reading-comparison with classical visual interpretation","volume":"14","author":"Mayr","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.rdc.2026.03.003_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.607541","article-title":"Evaluation of a fully automated antinuclear antibody indirect immunofluorescence assay in routine use","volume":"11","author":"Choi","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2026.03.003_bib87","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/diagnostics11040642","article-title":"Application of supervised machine learning to recognize competent level and mixed antinuclear antibody patterns based on ICAP international consensus","volume":"11","author":"Wu","year":"2021","journal-title":"Diagnostics"},{"issue":"9","key":"10.1016\/j.rdc.2026.03.003_bib88","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2026.03.003_bib89","doi-asserted-by":"crossref","first-page":"937","DOI":"10.5858\/arpa.2020-0419-CP","article-title":"Long-term variability in immunofluorescence titer of antibodies to nuclear antigens observed in clinical laboratory proficiency testing surveys","volume":"145","author":"Wener","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.rdc.2026.03.003_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103608","article-title":"Reflecting on a decade of the international consensus on ANA patterns (ICAP): accomplishments and challenges from the perspective of the 7th ICAP workshop","volume":"23","author":"Andrade","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2026.03.003_bib91","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3899\/jrheum.2025-0390.O032","article-title":"Machine learning can identify an antinuclear antibody pattern that may rule out systemic autoimmune rheumatic diseases","author":"Moghaddam","year":"2025","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2026.03.003_bib92","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/0961203317692437","article-title":"The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients","volume":"26","author":"Choi","year":"2017","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2026.03.003_bib93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/annrheumdis-2019-215694","article-title":"EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2026.03.003_bib95","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2023.04.005","article-title":"Artificial intelligence-driven drug development against autoimmune diseases","volume":"44","author":"Moingeon","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"7873","key":"10.1016\/j.rdc.2026.03.003_bib96","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.rdc.2026.03.003_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.168967","article-title":"AlphaFold protein structure database and 3D-Beacons: new data and capabilities","volume":"437","author":"Fleming","year":"2025","journal-title":"J Mol Biol"},{"issue":"7921","key":"10.1016\/j.rdc.2026.03.003_bib98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-022-02083-2","article-title":"\u2018The entire protein universe\u2019: AI predicts shape of nearly every known protein","volume":"608","author":"Callaway","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.rdc.2026.03.003_bib99","article-title":"Antibody structure prediction using interpretable deep learning","volume":"3","author":"Ruffolo","year":"2022","journal-title":"Patterns (N Y)"},{"issue":"24","key":"10.1016\/j.rdc.2026.03.003_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu1823","article-title":"AbEpiTope-1.0: improved antibody target prediction by use of AlphaFold and inverse folding","volume":"11","author":"Clifford","year":"2025","journal-title":"Sci Adv"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X26000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X26000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:35:35Z","timestamp":1785969335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X26000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0889857X26000323"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2026.03.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}